Roland Martin
Titel
Zitiert von
Zitiert von
Jahr
Immunology of multiple sclerosis
M Sospedra, R Martin
Annu. Rev. Immunol. 23, 683-747, 2005
24422005
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ...
Nature 476 (7359), 214, 2011
23152011
Immunological aspects of demyelinating diseases
R Martin, HF McFarland, DE McFarlin
Annual review of immunology 10 (1), 153-187, 1992
12181992
Multiple sclerosis: a complicated picture of autoimmunity
HF McFarland, R Martin
Nature immunology 8 (9), 913-919, 2007
10972007
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
AH Beecham, NA Patsopoulos, DK Xifara, MF Davis, A Kemppinen, ...
Nature genetics 45 (11), 1353, 2013
9092013
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
PH Clements, P Lachenbruch, J Siebold, B White, S Weiner, R Martin, ...
The Journal of rheumatology 22 (7), 1281-1285, 1995
9041995
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand
B Bielekova, B Goodwin, N Richert, I Cortese, T Kondo, G Afshar, B Gran, ...
Nature medicine 6 (10), 1167-1175, 2000
8712000
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
B Bielekova, M Catalfamo, S Reichert-Scrivner, A Packer, M Cerna, ...
Proceedings of the National Academy of Sciences 103 (15), 5941-5946, 2006
6272006
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways
I Štefanová, B Hemmer, M Vergelli, R Martin, WE Biddison, RN Germain
Nature immunology 4 (3), 248-254, 2003
4772003
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
R Martin, HF McFarland, JM Boggs
Critical reviews in clinical laboratory sciences 32 (2), 121-182, 1995
4561995
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
PA Muraro, DC Douek, A Packer, K Chung, FJ Guenaga, ...
The Journal of experimental medicine 201 (5), 805-816, 2005
4522005
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
N Sommer, PA Löschmann, GH Northoff, M Weller, A Steinbrecher, ...
Nature medicine 1 (3), 244-248, 1995
4071995
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
S Brocke, K Gijbels, M Allegretta, I Ferber, C Piercy, T Blankensteini, ...
Nature 379 (6563), 343-346, 1996
4041996
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
HF McFarland, JA Frank, PS Albert, ME Smith, R Martin, JO Harris, ...
Annals of neurology 32 (6), 758-766, 1992
3931992
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
R Martin, D Jaraquemada, M Flerlage, J Richert, J Whitaker, EO Long, ...
The Journal of Immunology 145 (2), 540-548, 1990
3921990
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
M Prinz, H Schmidt, A Mildner, KP Knobeloch, UK Hanisch, J Raasch, ...
Immunity 28 (5), 675-686, 2008
3752008
Identification of high potency microbial and self ligands for a human autoreactive class II–restricted T cell clone
B Hemmer, BT Fleckenstein, M Vergelli, G Jung, H McFarland, R Martin, ...
The Journal of experimental medicine 185 (9), 1651-1660, 1997
3681997
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
B Bielekova, N Richert, T Howard, G Blevins, S Markovic-Plese, ...
Proceedings of the National Academy of Sciences 101 (23), 8705-8708, 2004
3642004
Development of biomarkers in multiple sclerosis
B Bielekova, R Martin
Brain 127 (7), 1463-1478, 2004
3562004
A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis.
R Martin, MD Howell, D Jaraquemada, M Flerlage, J Richert, S Brostoff, ...
The Journal of experimental medicine 173 (1), 19-24, 1991
3201991
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20